![A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-61535-9/MediaObjects/41598_2020_61535_Fig1_HTML.png)
A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports
![IJMS | Free Full-Text | Thiosemicarbazide Derivatives Targeting Human TopoIIα and IDO-1 as Small-Molecule Drug Candidates for Breast Cancer Treatment IJMS | Free Full-Text | Thiosemicarbazide Derivatives Targeting Human TopoIIα and IDO-1 as Small-Molecule Drug Candidates for Breast Cancer Treatment](https://www.mdpi.com/ijms/ijms-24-05812/article_deploy/html/images/ijms-24-05812-g001.png)
IJMS | Free Full-Text | Thiosemicarbazide Derivatives Targeting Human TopoIIα and IDO-1 as Small-Molecule Drug Candidates for Breast Cancer Treatment
![Cancers | Free Full-Text | A Comparison between the Online Prognostic Tool PREDICT and myBeST for Women with Breast Cancer in Malaysia Cancers | Free Full-Text | A Comparison between the Online Prognostic Tool PREDICT and myBeST for Women with Breast Cancer in Malaysia](https://pub.mdpi-res.com/cancers/cancers-15-02064/article_deploy/html/images/cancers-15-02064-g001-550.jpg?1680170219)
Cancers | Free Full-Text | A Comparison between the Online Prognostic Tool PREDICT and myBeST for Women with Breast Cancer in Malaysia
![Cancers | Free Full-Text | piNET–An Automated Proliferation Index Calculator Framework for Ki67 Breast Cancer Images Cancers | Free Full-Text | piNET–An Automated Proliferation Index Calculator Framework for Ki67 Breast Cancer Images](https://www.mdpi.com/cancers/cancers-13-00011/article_deploy/html/images/cancers-13-00011-g001.png)
Cancers | Free Full-Text | piNET–An Automated Proliferation Index Calculator Framework for Ki67 Breast Cancer Images
![Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-021-00288-8/MediaObjects/41523_2021_288_Fig1_HTML.png)
Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer
![The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment | npj Breast Cancer The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment | npj Breast Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41523-021-00276-y/MediaObjects/41523_2021_276_Fig1_HTML.png)
The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment | npj Breast Cancer
![Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review](https://www.mdpi.com/cancers/cancers-14-01898/article_deploy/html/images/cancers-14-01898-g001.png)